Clinical Trial Update: Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 trial evaluating tranexamic acid to prevent the need for surgery in patients with chronic subdural hematoma. Recruitment is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Hematoma, Subdural, Chronic | Phase 3 | Status: RECRUITING